StemCell Therapy

TRAVERSE CITY His father had it. His maternal grandfather had it. So Ross Sussman assumed his Type 2 diabetes day of reckoning would come.

"It was just a question of when," said Sussman, 83.

But prepping for the diagnosis does not make living with it any easier, Sussman said, after "when" became official 20 years ago.

"Like many people, I enjoy sweets. I had to cut way back, and I lost weight in maybe the first couple years, but then it kind of stopped," Sussman said.

It took a toll on his wife, Evy, too. She tried not to police her husband's eating habits, but cherished social routines like post-movie-or-concert dining changed unpleasantly, she said.

"Socially, it just felt funny when you're ordering a salad when everybody else ordered strawberry pie," said Evy, 75.

But Ross' diabetes class last summer empowered them both, they said, as it combined clinical, group and follow-up approaches to positive behavior.

"It really encouraged me in the way that nobody else can make me do what I'm supposed to screw up my mind or unscrew it to do," Ross said. "It's different from making promises to myself, where I'd probably keep half of them."

The couple lives part time in Minneapolis, Minnesota, and part time in Northport, where the Area Agency on Aging of Northwest Michigan offered a pilot version of LIFE with Diabetes last summer.

The agency will offer the program to Grand Traverse area diabetics over 50 this spring.

The program kicks off with a consultation with a nurse diabetes educator and registered dietitian, and spouses and caretakers are encouraged to attend.

"I liked being included, " Evy said. "As many conditions are, it's a family issue."

The program continues with six weekly group sessions, then wraps up with a three-month post-program follow-up session.

It's geared to promote self management and encouragement for those who need it, said Darcia Brewer, AAANM's registered dietitian and program manager.

"Once you're diagnosed, you get the initial education session. But life changes, conditions change and we face so much more than diabetes," Brewer said. "No one ever can be perfect 100 percent of the time. Even people who know all the information get busy with life, and lax with what we're doing at different stages of the process."

Munson Healthcare's Community Dashboard shows almost a quarter of the 5-county area's Medicare population (over 65) has diabetes a trend that shows no signs of slowing, Brewer said.

"Statistically, with increases in obesity and the number of diabetics who go undiagnosed, it's unfortunate, but that will continue to grow," Brewer said.

They hope to offer the program in low-income housing and apply to Medicare for future funding, she said. The agency currently is offering initial consultations May 8-10 with group sessions May 23 to June 27 from 10 a.m. to 12:30 p.m. at the Area Agency on Aging of Northwest Michigan, at no cost.

Ross compared living with Type 2 to living on a stagecoach.

"It's moving, and some people are driving, some are running behind it, and others are just being pulled along," Ross said.

For more information or to register please call 1-800-442-1713 by April 28.

Session dates/times: Individual consultations will be offered May 8-10. Group sessions on Tuesdays, May 23 to June 27 from 10 a.m. to 12:30 p.m., at the Area Agency on Aging of Northwest Michigan, 1609 Park Drive.

Requirements: 50 or older who have Type 2 diabetes (and family caregivers) living in the greater Grand Traverse region. Registration is required by April 28.

Cost: No cost to attend but need a primary care physician referral.

Read more:
Diabetes program combines clinical, group and caregiver approach - Traverse City Record Eagle

OUTinPerth

Diabetes rising NJ TODAY In the United States, 29.1 million people are living with diagnosed or undiagnosed diabetes, and about 208,000 people younger than 20 years are living with diagnosed diabetes. This study is the first ever to estimate trends in new diagnosed cases of ... GRAI offer workshop for people with Type II DiabetesOUTinPerth all 2 news articles »

The rest is here:
Diabetes rising - NJ TODAY

By Dr. Allan Frankel, M.D. Greenbridge Medical

March 28, 2017 On Diabetes AlertDay it is fitting to discuss not only attempts at managing the disease, but also contributing factors and other conditions related to the disease.

For some time I have been recommending whole plant cannabis CBD for patients with Diabetes. We have seen a substantial lowering of their glucose levels in those with Type II Diabetes including several patients Hemoglobin A1C levels normalize so they are able to stop their Type II Diabetes medications.

The first time I saw this with a Diabetic, he called me after having some hypoglycemic episodes while taking CBD in addition to his Metformin. I told him to stop his Metformin and continue his CBD. His glucose levels normalized and he remained off Metformin. This is a good demonstration of blood sugar control over a three-month period. With any patient with Type II Diabetes, I warn them about this.

With regard to cholesterol, Diabetes can raise bad cholesterol levels and lower good cholesterol levels. Once a patients blood sugar levels are stable, if they are on a statin I will often discuss with the patient and their primary care doc, the idea of stopping the statin and monitoring their cholesterol levels. The drop in cholesterol is not overnight. It can take some months for reasons we dont yet understand. However, we are seeing improvements in cholesterol levels and many patients remain off their statins.

We have also seen improvements ranging from apparent stabilization of macular degeneration and help with neuropathic pain. Sometimes combined with THC, CBD is a vascular and renal protectant.

Finally with regard to weight and Diabetes, there is certainly a connection to being overweight and the onset of Diabetes. I have written about the effect of CBD on curbing appetite before. The ability to achieve weight loss with CBD is real.

So, when discussing CBD and Diabetes, it is a multi-pronged approach. Helping patients with weight, cholesterol and glucose issues. I believe this is all happening on a number of metabolic levels, such as bringingthe sensitivity of insulin back to normal.

So, help with many major issues resulting from, and associated with diabetes can be achieved with CBD. For certain, it is worth a try.

2017 Greenbridge Medical. All rights reserved. Posted by special permission. Original article appeared here.

The rest is here:
Diabetes-More Than Blood Sugar - Oregon Cannabis Connection

Small losses, big gains artyme83/Shutterstock"Because most people diagnosed with type 2 diabetes are overweight, meal planning and physical activity usually focus on gradual weight loss, something on the order of two to three pounds per month, " says Paris Roach, MD, an endocrinologist with Indiana University Health and the Division of Endocrinology and Metabolism at the Indiana University School of Medicine. "Exercise is beneficial to metabolism independent of weight loss in that it lowers glucose levels and improves insulin resistance," says Dr. Roach. Just a five to ten percent reduction from your starting weight can have significant effects on blood glucose levels. That's good news if you haven't broken a sweat in a while. In addition, you'll also gain muscle strength, improve cardiovascular fitness, flexibility, balance, stamina, mood and overall good feeling. This workout normalizes blood sugar for type 2 diabetics. Keep an eye on blood sugar Syda Productions/ShutterstockExercise will not only help control blood sugar levels but also help you shed weight and keep your heart healthy. It's important you keep an eye on your blood sugar because any physical activity makes you more sensitive to insulin. "When you exercise, your body becomes more efficient at using insulin and this can lower blood sugar, both during exercise and up to 24 hours after," says Mark Heyman, clinical psychologist, certified diabetes educator, and vice-president of Clinical Operations and Innovation at One Drop, a mobile app that educates and coaches diabetics. Because blood sugar can drop dangerously low, check it before you exercise and again if you feel light-headed or weak during exercise, he says. "If your blood sugar is low (below 70mg/dl), eat 15 grams of simple carbohydrates, such as orange juice, glucose tablets or candy," says Dr. Heyman.

Content continues below ad

Content continues below ad

Content continues below ad

Dragon Images/ShutterstockManaging type 2 diabetes may seem like a tiresome task, but as you begin to manage your blood pressure, you will feel better. "Physical activity does not need to be complicated," says Andrea M. Sosa-Melo, MD, physician and educator at Pritikin Longevity Center + Spa. "A daily brisk walk can help you live a healthier life." Remember, that 10-minute increments are just as effective as full-length session. Melo encourages wearing a pedometer. "Put it on in the morning and see how many steps you take in an average day, and then try to increase that number each week." Check out these easy-to-accomplish ideas from Melo:

Content continues below ad

Read more here:
Subscribe to Print: - Reader's Digest

Crain's Detroit Business

Michigan tests 'pay- for-success' model for diabetes prevention Crain's Detroit Business The model is set to get another early test drive in Michigan, expanding a proven diabetes prevention program offered by the National Kidney Foundation of Michigan in six Metro Detroit and West Michigan counties. For nonprofits, the model promises a new ...

Read the original here:
Michigan tests 'pay- for-success' model for diabetes prevention - Crain's Detroit Business

Eating a diet with a higher amount of plant protein may reduce the risk of developing type 2 diabetes, according to researchers from the University of Eastern Finland. While plant protein may provide a protective role, meat protein was shown to increase the risk of type 2 diabetes.

More than 29 million people in the Unites States are affected by diabetes, with type 2 diabetes accounting for between 90 and 95 percent of all cases. An essential part of managing diabetes is partaking in regular physical activity, taking medications to lower blood glucose levels, and following a healthful eating plan.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, healthy eating consists of consuming a variety of products from all food groups, with nonstarchy vegetables taking up half of the plate, grains or another starch on one fourth of the plate, and meat or other protein comprising the final fourth.

It is recommended that fatty or processed meat should be avoided and that lean meat, such as skinless chicken, should be opted for as an alternative.

Meat consumption has frequently been explored as a variable associated with diabetes, and previous research has found a link between a high overall intake of protein and animal protein, and a greater risk of type 2 diabetes. Eating plenty of processed red meat, in particular, has been connected with the condition.

The new research - published in the British Journal of Nutrition - adds to the growing body of evidence suggesting that the source of dietary protein may be important in altering the risk of developing type 2 diabetes.

The researchers set out to investigate the links between different dietary protein sources and type 2 diabetes risk. They used data from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD), which was carried out at the University of Eastern Finland.

When the KIHD study began in the years between 1984 and 1989, the diets of 2,332 men aged 42 to 60 years old were assessed. None of the individuals had type 2 diabetes at the onset of the study. Over the course of the 19-year follow-up, 432 men were diagnosed with type 2 diabetes.

Jyrki Virtanen, a certified clinical nutritionist and an adjunct professor of nutritional epidemiology at the University of Eastern Finland, and colleagues discovered that a diet high in meat was associated with an increased risk of type 2 diabetes. The association was seen across all types of meat in general, including processed and unprocessed red meat, white meat, and variety meats.

The researchers say that the association may be a result of other compounds found in meat other than protein, since meat protein alone was not connected with the risk of type 2 diabetes.

Men who included a higher intake of plant protein in their diets also had healthier lifestyle habits. However, their lifestyle habits were not shown to fully explain their reduced risk of diabetes.

Male study participants who had the highest intake of plant protein were 35 percent less likely to develop type 2 diabetes than men with the lowest plant protein intake. Furthermore, using a computer model, Virtanen and team estimate that replacing around 5 grams of animal protein with plant protein per day would diminish diabetes risk by 18 percent.

The link between plant protein and reduced diabetes risk may be explained by the effect of plant protein in the diet on blood glucose levels. Those people who consumed more plant protein had lower blood glucose levels at the start of the study.

The primary sources of plant protein in this study were grain products, with additional sources including potatoes and other such vegetables.

A diet preferring plant protein to meat protein may help protect against type 2 diabetes. The authors conclude that:

"Replacing 1 percent of energy from animal protein with energy from plant protein was associated with [an] 18 percent decreased risk of type 2 diabetes. This association remained after adjusting for BMI. In conclusion, favoring plant and egg proteins appeared to be beneficial in preventing type 2 diabetes."

Overall protein, dairy protein, and fish protein were not connected with a risk of type 2 diabetes, the researchers note. The team also revealed that, confirming the group's earlier studies, a higher intake of egg protein was identified as able to lower the risk of type 2 diabetes.

Learn how legumes may reduce the risk of type 2 diabetes.

Read the original here:
Diet rich in plant protein may prevent type 2 diabetes - Medical News Today

According to researchers, the results of their study illustrate the importance of intestinal bacteria's contribution to the operation of diet, metabolism and health interface.

Results were published in Scientific Reports magazine. The study was conducted at the University of Eastern Finland LC-MS-metabolomiikkakeskuksessa. The partners had a large number of Finnish and Swedish experts.

The study compared two groups who took part in a wider Diabetes Prevention study (DPS). Everyone had at the beginning of the study excess weight and impaired glucose tolerance. During 15 years of follow-up part of the ill with type 2 diabetes, some not. Differences between these two groups studied the unallocated metabolomics analysis. It can be studied to determine the metabolic profile of a concentration of a large number of metabolites rather than examining only a few of the predetermined marker.

The main differences with type 2 diabetes affected and unaffected metabolism profiles was observed at concentrations of the indole propionic acids and certain lipid metabolism products.

High serum concentration of the indole propionic acids were protected with diabetes illness. Indole propionic acids are intestinal bacteria metabolite. A generous use of whole grains, dietary fiber boosted its content. Indolipropionohapon a greater amount of the pancreatic beta-cell insulin secretion appeared to remain preferred, which may explain the protective effect.

Indole propionic contacting the risk of diabetes explained DPS material in addition to the two population-based study file, the file METSIM Finnish and Swedish VIP material. Also, there it turned out to be diabetes protective factor.

The study identified several new lipid metabolism products, with a high concentration was associated with improved insulin sensitivity and reduced the risk of diabetes. These metabolites content of the higher, the less of saturated fat diet. They, as well as the indole propionic acids, showed a high concentration of the protective body in low-grade inflammation of the farm.

- intestinal bacteria have been found in other studies to affect the risk of developing excess weight. In light of these results, the indole propionic acids may be one factor that mediates diet and intestinal bacteria a protective effect, academy researcher Kati Hanhineva says.

Direct determination of intestinal bacteria is difficult, so produced by the metabolism of intestinal bacteria intermediates assay may be useful in methods to examine the role of intestinal bacteria such as diabetes pathogenesis.

The DPS is the first randomized controlled lifestyle intervention study, which demonstrated that type 2 diabetes is preventable lifestyle changes in subjects with impaired glucose tolerance. Major lifestyle changes were weight loss, increased physical activity and a change in diet more in line with the recommendations of, for example, whole grain cereals, fruit and vegetables with respect to the use.

This article has been republished frommaterialsprovided byUniversity of Eastern Finland. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference

de Mello, V. D., Paananen, J., Lindstrm, J., Lankinen, M. A., Shi, L., Kuusisto, J., ... & Bergdahl, I. A. (2017). Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Scientific Reports, 7.

See original here:
Gut Bacteria Offers Protection from Type 2 Diabetes - Technology Networks

Most cystic fibrosis diagnoses today require sitting for 30 minutes while an instrument collects sweat.

That bodily fluid is usually transported off-site to a lab for analysis.

Researchers then look at chloride ion levels in the sweat for indicators of the genetic disease.

Its a long process. Many, many steps are involved and technicians involved and a lot of time, so the sample can get contaminated or degraded, said Sam Emaminejad, head of the Interconnected and Integrated Bioelectronics Lab at the University of California, Los Angeles (UCLA).

But Emaminejad has helped create a new device that may help solve those problems.

Its a sensor that collects sweat, analyzes its molecular makeup, and transmits the results for diagnosis.

All of that technology is contained in one wearable device.

This can be programmed to do it all on its own, to switch from extraction to testing in a self-contained device, Emaminejad told Healthline.

His findings were published this past week in the journal Proceedings of the National Academy of Sciences (PNAS).

Read more: A watch that tells you when youre getting sick

The sweat sensor is the first step in what Emaminejad hopes will become an ecosystem of sensors monitoring physiological signals in our blood, sweat, and urine.

Its also part of a broader revolution in bioelectronics that is helping to achieve faster, more accurate, and more convenient diagnoses.

Alphabet Inc., the owner of Google, has a dedicated life sciences arm, Verily Life Sciences. It also has a joint venture with GlaxoSmithKline and Galvani Bioelectronics.

The Silicon Valley firm is said to be developing products such as contact lenses that can track blood sugar levels.

Researchers at Cornell University are working on slashing the time it takes to diagnose strokes through a technology that requires just a drop of blood. The process lights up substances in blood tied to a recent stroke.

Ultrasound machines are getting smaller and smaller.

Smartphone apps can help monitor how strong tremors are in Parkinsons patients, and the severity of a head injury.

And Apple reportedly has a secret team of biomedical engineers working on noninvasive blood sugar sensors that could help treat diabetes.

Monitoring blood sugar levels without piercing the skin has been seen as a holy grail by diabetes researchers.

This sort of monitoring may be a big part of the future of wearable devices like the Apple Watch as well as the future of diagnosing, tracking, and treating our health.

Read more: Re-growing teeth and healing wounds without scars

Emaminejads device also takes on this futuristic quest.

In addition to testing its role as a diagnostic tool for diseases like cystic fibrosis, his team has examined whether high glucose levels in blood correlate to high levels in sweat.

That would make analyzing the composition of sweat a quicker, noninvasive way of monitoring.

In a small early trial, the correlation was there.

Its all part of what Emaminejad sees as the future of the internet of things and wearable technology.

Right now, the Apple Watch and similar products can only tell us macro things like steps and heart rate, Emaminejad said. If we want to really make smartwatches useful for health monitoring we need to think beyond heart rate and measure micro- and nano-scale particles like electrolytes and proteins.

Being able to capture and analyze something like sweat would be a natural application of wearable tech.

A new drug could come out that doesnt work on every patient with a particular ailment, for instance.

Wearables could be used to test in real time how patients respond and adjust their treatment.

One day, these technologies could be combined to create a monitoring network scanning our blood, sweat, urine, movements, eyes, and anything else that can be analyzed to make sure everything is working as it should.

There are some biomarkers in blood that arent in sweat, and vice versa, said Emaminejad.

He said his labs new device is a good proof of concept and a first step toward that connected future.

Read more: Hip replacement surgery in one day

Excerpt from:
Wearable Technology That Can Diagnose Diabetes, Cystic Fibrosis - Healthline

Patch.com

Last Hurrah For Foxborough Against Diabetes 5K Patch.com FOXBOROUGH, MA The 17th running of the Foxborough Against Diabetes 5K will be the last for long-running charity run. Friday night, the event organizers announced on Facebook that the race will not be continued beyond 2017. No reason was given ...

Visit link:
Last Hurrah For Foxborough Against Diabetes 5K - Patch.com

by Delaine Mathieu, News 4 San Antonio

Good 4 You: Mental fitness for diabetes

There's a unique new therapy group in San Antonio designed to help people living with diabetes cope with the disease. It's called Mental Fitness for Diabetes. The goal of the program is to help treat mental side-effects that come along with diabetes. "I remember when I was diagnosed with diabetes," said Sarah Villegas. "March 31 for 2016. So, it's been a year."

The 71-year-old registered nurse was completely surprised when she was diagnosed with type two diabetes. "When the doctor came in and showed me my lab results," she explained. "I looked at the paper and I said, are you kidding me?"

Villegas lost seventeen pounds and got her condition under control. When she heard about this new mental fitness group, she was pleasantly surprised. "Never in my 49 years as a registered nurse -- to combine diabetes, a major chronic illness with a major mental health illness, which is chronic, and put them together -- that is an awesome concept," she said.

Valerie Moczgemba, with Alamo Wellness Group, will be running the sessions. "A lot of times, people who have been diagnosed with diabetes experience depression anxiety," she said. "There also may be anger or irritability. She said they'll be focusing on disease management and how mental health symptoms play into disease management.

Villegas says it's high time a treatment like this is made available for people with diabetes. "It cannot be ignored," she said. "We need to address their physical health issues as well as the mental issues. They both go hand-in-hand."

April 30th is the last day to register. If you're interested in signing up, go to alamowellnessgroup.com.

Go here to see the original:
Good 4 You: Mental fitness for diabetes - WOAI

Thursday, April 20, 2017 5:03 p.m. EDT

By Will Boggs MD

(Reuters Health) - For people with type 2 diabetes, maintaining good blood sugar control in the years after receiving a coronary artery stent is associated with a lower risk of heart attack and stroke, according to a recent study.

Although intensive glucose control had no benefit on the rate of major cardiovascular events in previous studies, our data suggest that strict glucose control after PCI (heart catheterization) can improve long-term clinical outcomes in diabetic patients, Dr. Joo-Yong Hahn from Samsung Medical Center in Seoul told Reuters Health.

Heart disease is the major cause of death among people with type 2 diabetes, Hahns team writes in Circulation: Cardiovascular Interventions. Although intensive blood sugar control is known to reduce damage to tiny blood vessels that are involved in many of the nerve and circulatory effects of diabetes, its not clear if the same is true for major arteries such as the ones that carry blood to the heart.

The researchers studied 980 patients with type 2 diabetes who had undergone percutaneous cardiac intervention (PCI) to clear a blocked coronary artery and place a supportive mesh tube known as a stent. Hahns team followed the patients health for up to seven years.

They looked at long-term blood sugar control using a measurement known as hemoglobin A1c (HbA1c or A1C), and used it to compare the patients risks of death, heart attack, repeat catheterizations and stroke over the study period.

The researchers defined good control as an A1C score below 7.0 and poor control as A1C of 7.0 or higher. Then they matched patients according to other risk factors and ended up with 322 pairs of patients for comparison.

In the overall group of 980 patients, the risk of all bad outcomes was 25 percent lower with good blood glucose control than with poor blood glucose control.

In the matched comparison, some 37 percent of patients with poor control had bad outcomes (heart attack, stroke, and so on) over the next seven years, versus less than 28 percent of patients with good control. Most of the difference in bad outcomes between the groups resulted from a higher rate of repeat stenting in the group with poor blood glucose control.

PCI is not the end of treatment for coronary artery disease, Hahn said by email. Optimal medical treatment, including glycemic control, is a cornerstone therapy after PCI, he said.

The effects of glucose control in type 2 diabetes may differ according to patient characteristics, such as recent cardiovascular events, baseline glycemic control status and duration of diabetes, Hahn added.

The researchers write that more study is needed before they can conclude strict glucose control after stenting will improve long-term clinical outcomes in people with diabetes.

Its important to underscore the message of good glycemic control, said Dr. Azfar G. Zaman from Newcastle University in the UK. He was not involved in the study but has done similar research. In patients with PCI there is evidence to support better outcomes and need for fewer interventions, Zaman said by email.

This is a single center study with limited numbers, but the findings support data from other studies, he noted.

SOURCE: http://bit.ly/2pjU0al Circulation: Cardiovascular Interventions, online April 3, 2017.

View post:
Diabetes control tied to heart stent outcomes - WHTC

On Thursday, Lodis Day 2 Day Diabetes Support Group will host a panel of experts on the illness, and the public is invited to attend.

Our support group is being flooded with question after question by the increasing number of people being recently diagnosed with diabetes, group founder Duane Simpfenderfer Sr. said. These type of question and answer sessions provide us with the best way to help people.

An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.

If you are a current print subscriber to the Lodi News-Sentinel (and are not subscribed as a business), please choose this option for FREE online access. You will need to know your account number to finalize accessing this service. If you do not know your account number, please contact us at 209-333-1400.

If you are a business with a current print subscription to the Lodi News-Sentinel, please choose this option for FREE online access. You will need to know your account number to finalize accessing this service. If you do not know your account number, please contact us at 209-333-1400.

Need an account? Create one now.

kAmpE E96 >66E:?8[ 7@FC 6IA6CED @? 5:236E6D 7C@> 2 G2C:6EJ @7 7:6=5D H:== E2<6 BF6DE:@?D 7C@> E96 2F5:6?46 2?5 D92C6 E96 =2E6DE C6D62C49 :?E@ E96 :==?6DD[ :ED 42FD6D 2?5 A@E6?E:2= EC62E>6?ED]k^Am

kAmp=D@ 😕 2EE6?52?46 H:== 36 DFAA@CE 8C@FA >6>36CD H9@ 92G6 364@>6 6IA6CED @? 5:236E6D EJA6 `[ EJA6 a 2?5 C6=2E65 :==?6DD6D 27E6C 36:?8 5:28?@D65 E96>D6=G6D]k^Am

kAm$@>6 92G6 366? =:G:?8 H:E9 E9:D 5:D62D6 7C@> 2D =:EE=6 2D 2 76H >@?E9D E@ 2D =@?8 2D de J62CD[ $:>A76?56C76C D2:5]k^Am

kAm%96 DFAA@CE 8C@FA 564:565 E@ @C82?:K6 E96 A2?6= ?@E @?=J 3642FD6 E96J H6C6 D66:?8 >@C6 >6>36CD @7 E96 {@5: 4@>>F?:EJ D66<:?8 @FE 96=A 2?5 25G:46[ 3FE 2=D@ 3642FD6 E96JG6 366? ?@E:4:?8 2 C:D6 :? 5:28?@D6D]k^Am

kAm$:>A76?56C76C 4:E65 2 C646?E DEF5J 3J D4:6?E:DED 2E E96 &?:G6CD:EJ @7 r2=:7@C?:2[ {@D p?86=6D E92E :?4=F565 >@C6 E92? `e[___ A2CE:4:A2?ED] %96 DEF5J 7@F?5 E92E 2D >2?J 2D cg A6C46?E @7 2== 25F=ED @G6C E96 286 @7 a` 😕 E96 &]$] >2J 92G6 EJA6 a 5:236E6D @C AC65:236E6D] W%96 DEF5J 6I4=F565 C6DA@?56?ED H:E9 EJA6 ` 5:236E6D]Xk^Am

kAm(96? E9:D DEF5J 2?5 E96 4@?4=FD:@?D E92E 7@==@H65 H6C6 >256 2G2:=23=6[ :E D9@4<65 E96 >65:42= AC@76DD:@?[ $:>A76?56C76C D2:5]k^Am

kAm%92ED H9J s2J a s2J s:236E6D D66

kAmp?J {@5: C6D:56?ED H9@ 92G6 BF6DE:@?D 23@FE E96 :==?6DD D9@F=5 4@>6 @? %9FCD52J[ $:>A76?56C56C D2:5]k^Am

kAmqC:?8 2 7C:6?5[ C6=2E:G6[ ?6:893@C @C 2?J@?6 H9@> J@F 36=:6G6 H:== 36?67:E 7C@> =62C?:?8 23@FE G2C:@FD 962=E9 4@?46C?D[ 96 25565]k^Am

kAmx? 255:E:@? E@ %9FCD52JD A2?6=[ E96 DFAA@CE 8C@FA >66ED @? E96 E9:C5 %9FCD52J @7 6249 >@?E9] |66E:?8D 2C6 @A6? E@ E96 AF3=:4[ 2?5 @7E6? 7@4FD @? 962=E9 2?5 5:236E6D 65F42E:@?]k^Am

Read the original post:
Day 2 Day Diabetes Support Group to meet with experts on the illness - Lodi News-Sentinel

By Alan Mozes

HealthDay Reporter

WEDNESDAY, April 19, 2017 (HealthDay News) -- People with type 1 diabetes face the risk of developing a disease that can cause blindness, so treatment guidelines have long called for annual eye exams.

But new research suggests this one-size-fits-all advice is costly and ineffective, because people with a low risk may need less-frequent screenings while people at high risk may need to be seen more often.

Diabetic retinopathy can damage the light-sensitive tissue at the back of the eye and trigger full vision loss, the researchers explained. Screening can catch this disease before irreparable damage is done, but not every person with diabetes faces the same risk.

"For example, patients with no or minimal eye changes and good blood sugar levels might not need their next examination for another four years," said study author Dr. David Nathan.

"On the other hand, if the patient already has developing eye disease and their blood sugar control has not been in the recommended range, they might need a repeat examination in as soon as three months," he added.

Nathan is the director of the Diabetes Center and Clinical Research Center at Massachusetts General Hospital, in Boston.

Current guidelines suggest getting an annual eye screening within three to five years of a type 1 diabetes diagnosis. People with type 1 diabetes cannot produce any insulin.

To assess that advice, the investigators focused on type 1 diabetics (aged 13 to 39) who had enrolled in a large, national diabetes trial between 1983 and 1989.

The latest analysis involved 24,000 eye exams conducted over 30 years among roughly 1,400 people with type 1 diabetes.

Retinal photographs were taken every six months until 1993, and then -- in a follow-up study -- once every four years until 2012. The study participants' vision, advanced retinopathy status and general diabetes history were tracked for an average of nearly 29 years.

The researchers determined that those participants who had an average blood sugar level of 6 percent, but no signs of retinopathy, could forgo the annual screening in favor of just one exam every four years. Similar people with mild retinopathy should be screened once every three years, the team concluded.

By contrast, those with severe or moderate retinopathy would do well to get screened every three to six months, respectively, the study authors reported.

People with higher blood sugar levels (8 to 10 percent) might also need to be screened more often, the researchers cautioned.

On average, the new recommendations for people with type 1 diabetes would likely cut the need for eye exams in half over a two-decade period. That would translate into an overall savings of $1 billion, while ensuring that those facing the highest risk got more timely treatment, the researchers said.

The findings were published in the April 20 issue of the New England Journal of Medicine.

Nathan described the results as "definitive." However, he said the jury is still out as to "whether the individualized frequency of eye examinations will be implemented by physicians" and followed by people with type 1 diabetes.

"The risk is that physicians may find it easier to schedule an annual eye examination compared with the new individualized schedule, which may be more difficult for physicians and patients to remember," he acknowledged.

"However, most physicians and ophthalmology offices use computer programs -- including reminder programs -- for scheduling, so we think that this potential barrier should not be a substantial obstacle," Nathan added.

Courtney Cochran, senior manager of media relations for the American Diabetes Association (ADA), noted that the ADA issued updated guidelines for retinopathy screenings in February.

The new recommendations now state that people with type 1 diabetes should start annual screenings within five years of their diabetes diagnosis. But those who remain free of retinopathy for a year or two may "consider" the option of less-frequent exams.

However, the ADA also said that if and when "any level" of retinopathy is detected, annual screenings are a must, while those with progressing retinopathy will require even more frequent screenings.

Dr. Jamie Rosenberg, who wrote an editorial that accompanied the study, suggested the new recommendations reflect "a trend toward reducing unnecessary screening for eye diseases."

"The upside to this new screening protocol would be significant money saved for the health care system, in addition to time saved for both patients and doctors," said Rosenberg, who is an associate professor of clinical ophthalmology and visual sciences at the Albert Einstein College of Medicine, in New York City.

Individualized schedules will make tracking patients more difficult, Rosenberg agreed. But, "this new screening protocol has great potential if adherence to the examination schedule could be assured."

WebMD News from HealthDay

SOURCES: David Nathan, M.D., director, Diabetes Center and Clinical Research Center, Massachusetts General Hospital, and professor, medicine, Harvard Medical School, Boston; Jamie Rosenberg, M.D., associate professor, clinical ophthalmology & visual sciences, and associate professor, clinical pediatrics, Albert Einstein College of Medicine, and attending physician, Montefiore Health System, New York City; Courtney Cochran, senior manager, media relations, American Diabetes Association; April 20, 2017, New England Journal of Medicine

Read more:
Is Annual Eye Exam a Must for Type 1 Diabetes? - WebMD

CARSON CITY Patients and family members of those who suffer from diabetes shared stories of struggle and heartbreak Wednesday and urged support for a bill to rein in the escalating costs of diabetes medication.

Bonnie Sedich knows the pain all too well. Four of her five children were diagnosed with juvenile diabetes. There was no family history. Two children died when in adulthood. Two others live with the disease.

One son, Jeffrey, was diagnosed at age 3. His body was found in a rural California region in 1981, a bottle of insulin by his side. He died at 19.

Another daughter, Elizabeth, was diagnosed when she was 8. She died in November at 51 of complications from the disease. Over the years, the cost of her drugs skyrocketed from about $10 a bottle to more than $300. Toward the end, she was paying more than $2,100 a month if she could afford it, Sedich said.

If you cant afford your diabetes medications then you just suffer and die, Sedich said.

She and others spoke at a press conference to urge support for Senate Bill 265. Sponsored by state Sen. Yvanna Cancela, D-Las Vegas, the bill would establish a list of insulin-related diabetic products to be treated as essential medications. It also would create a refund when insulin costs exceed the medical consumer price index.

The bill would require drug makers to divulge how prices are set, including the cost of medications, as well as amounts spent on marketing and research. It would set registration and reporting requirements on pharmaceutical sales representatives.

Diabetes is a serious disease that affects people for a lifetime, Cancela said. Medical costs are twice as high for people with diabetes.

Deadly and common

Diabetes is the eighth-leading cause of death in Nevada, where 12.4 percent of adults have the disease and 38 percent are pre-diabetic, she said.

Senate Majority Leader Aaron Ford, D-Las Vegas, is one of those who have been determined to be pre-diabetic. He said he received he diagnosis about a year ago.

Diabetes has become one of the largest public health crises in our time, and the medication to treat this disease must be affordable and accessible, he said. In this time of crisis, we have to come together.

Keyonna Lawrence said she was diagnosed as diabetic three years ago. A personal care assistant, she tries to control the disease through diet, and she stretches mediations when she can afford it by taking a half-dose.

My biggest fear is my 11-year-old son is going to wake up, say, Mom? and Moms as cold as ice, Lawrence said.

SB265 was granted an exemption and waiver from deadlines and remains pending in the Senate.

Contact Sandra Chereb at schereb@reviewjournal.com or 775-461-3821. Follow @SandraChereb on Twitter.

Sen. Yvanna Cancela, sponsor of Senate Bill 265, said diabetes care cost Nevadans about $2.4 billiion annually in medical costs.

Over the last 20 years, vials of the most commonn insulin products have gone from $17 to $138; and $21 to $255.

According to the American Diabetes Association, 281,355 people in Nevada, or 12.4 percent of the adult population, have diabetes. Another 787,000, or 38.5 percent of the adult population are pre-diabetic with blood glucose levels higher than normal.

Read more:
Family members of diabetes patients plead for law to limit ... - Las Vegas Review-Journal

by Zack Hedrick, Fox San Antonio

Researchers discover technique that could lead to diabetes cure

SAN ANTONIO Doctors in San Antonio have made a breakthrough discovery which could mean a potential cure for people with diabetes.

Tom Mathieu is a fanatical bike rider.

He believes he's pedaled more than 20,000 miles since he began riding in his early thirties.

He started riding because of a condition he was diagnosed with as a teenager.

Doctors told me it'd be a miracle that you see 60," said Mathieu.

Mathieu is a type 1 diabetic and his doctors tell him his body produces zero insulin.

He and his doctors believe his bike riding has helped keep his diabetes in check.

Well I'm 73 and I've had [diabetes] since I was 14," said Mathieu.

Researchers at UT Health San Antonio have discovered a strategy that could mean a cure.

It's a game changer, said Dr. Bruno Doiron. It change drastically the life of a patient that's diabetic."

Using a technique called gene transfer, doctors can alter other cells so they start to secrete insulin but only in response to sugar.

"Im using already what's naturally in your body," said Dr. Doiron.

The University Health System says diabetes is the 4th leading cause of death in Bexar County.

Mathieu calls the potential therapy revolutionary.

He says diabetes is a condition that requires discipline, but says this discovery would give a lot of freedom back to people dealing with diabetes.

People won't be burdened by what diabetes causes and then the cost of those causes, said Mathieu. I think it's miraculous."

Doctors say the therapy has cured diabetes in mice for one year without any side effects, which has never been done.

The goal is to conduct large-animal studies and human clinical trials in the next three to five years.

Facebook | Twitter |Email

Link:
Researchers discover technique that could lead to diabetes cure - FOX 29

(Reuters Health) - A short questionnaire can identify drivers with type 1 diabetes who are at high risk of future driving mishaps, and an online intervention can help them avoid these mishaps, according to a U.S. study.

Like pilots who have to go through a pre-flight checklist to ensure all systems are a go, drivers with diabetes should go through a check list, asking themselves whether they have had more physical activity, taken more insulin, eaten fewer carbohydrates than usual, feel any unusual symptoms and judge whether they are low or likely to go low during the drive, said lead author Dr. Daniel Cox from the University of Virginia Health System and Virginia Driving Safety Laboratory in Charlottesville.

If the answer is yes, then they should take appropriate steps to avoid hypoglycemia while driving, Cox said by email.

Drivers with type 1 diabetes have a greater risk of collisions than their spouses without diabetes, and those mishaps correspond to the use of insulin pumps, a history of collisions, severe low blood sugar (hypoglycemia) and previous hypoglycemia-related driving mishaps, the study team writes in Diabetes Care.

The researchers developed an 11-item questionnaire to screen drivers with type 1 diabetes for a high risk of driving mishaps and developed an online intervention intended to help high-risk individuals avoid future mishaps.

Their Risk Assessment of Diabetic Drivers (RADD) scale included questions about past experiences while driving, like have you had an automobile accident or received a moving vehicle violation in the last 2 years? and diabetes-specific questions like, have you had low blood glucose in the past 6 months? and was it a hassle trying to hide dizziness or other symptoms of low blood glucose?

Based on answers to 11 questions, around 35 percent of individuals with type 1 diabetes could be classified as high-risk drivers whose mishap rate was nearly three times higher than that of people in the low-risk group.

High-risk drivers who went on to participate in the online intervention at DiabetesDriving.com had a driving mishap rate of about 2.5 per year in the following 12 months, compared with about 4.25 mishaps per year among high-risk drivers who did not participate in the intervention. Still, the mishap rate of high-risk drivers who did the intervention remained higher than that of low-risk drivers.

Driving is a privilege, not a right, Cox said. Whether we have type 1 diabetes, sleep apnea, narcolepsy, slowed reaction times due to aging, or some other chronic or acute condition (e.g., excessive sleepiness or intoxication), we all have a responsibility to ourselves, our families, and others on the road to ensure we are a safe driver.

People with diabetes should realize they should never drive when their blood glucose is below 70, because it is too easy to slip from mild hypoglycemia to moderate hypoglycemia that impairs judgment, information processing speed, and general reaction time, Cox added. As soon as hypoglycemia is detected or suspected, the driver should immediately safely pull off the road, treat it, and not resume driving until the hypoglycemia resolves.

Diabetic patients have a tendency not to disclose their driving mishaps or near miss events due to fear of losing their driving licenses," said Dr. Thinzar Min from Swansea University in the UK, who was not involved in the study.

In the UK, drivers are allowed only one severe hypoglycemic episode in 12 months to retain Group 1 license (cars and motorcycles) and no severe hypoglycemic episodes for Group 2 licenses (trucks and busses), Min noted.

I think the RADD scale would be more accurate if the patients can use it to assess themselves if they are high-risk or not, she said. Online interventions should be aimed at all diabetic patients who are taking insulin.

Dr. Eitaro Nakashima from Chubu Rosai Hospitalin Nagoya, Japan, wrote recently about the pitfalls of tightening driving regulations for diabetic patients in Japan and Europe. "In my opinion, each patient should understand the degree of risk of driving mishaps and prepare sugar in their car. For general public, education and individual customized treatment are important for good outcome instead of tightening of driving regulations, he told Reuters Health by email.

SOURCE: bit.ly/2oJgxvQ Diabetes Care, online April 12, 2017.

(Reuters Health) - People who live near sources of heavy traffic exhaust may be at higher risk of heart disease because the fine particles in this type of pollution lower levels of good cholesterol needed for healthy blood flow, a U.S. study suggests.

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.

Continued here:
Program identifies risky diabetic drivers and helps them improve - Reuters

LEWISBURG Pamela Dixon of Shamokin Dam recently celebrated her 39th birthday. Christy Kerstetter of McAlisterville will turn 39 years old this July.

Both women are married and are raising boys.

Both women are also diabetic. Dixon is a Type 1, and Kerstetter is a Type 2.

So whats the difference and how does it impact each womans life?

Karen Dohl, PA-C, Diabetes Center of Evangelical, West Branch Medical Center explained the difference.

A Type 1 scenario is an autoimmune disease or a situation where the body is attacking itself.

They develop antibodies that kill off an area of the pancreas and the patient needs insulin to sustain life, Dohl said, adding that it is not curable.

A Type 2 diabetic has a high blood sugar level because the pancreas can not keep up with the body. This can be due to being overweight or other health issues and is often genetic.

Some patients no longer produce insulin on their own, Dohl said. When that happens, the Type 2 patient becomes what is known as Type 2 insulin dependent.

Dohl said sometimes patients get confused and think that if they need insulin they must be a Type 1.

All Type 1 diabetics need insulin on a regular basis to survive, but only some Type 2 patients reach this point.

Many Type 1 patients are diagnosed around the age of puberty.

Dr. John Kennedy specializes in Diabetes and Endocrinology, Diabetes and Metabolism and is employed within the Geisinger Health System in Danville.

He explained that at puberty a relative lack of insulin becomes absolute in these patients. He said that Type 1 can be diagnosed at any age, as early as toddlerhood; though this age group makes up one percent of Type 1 diagnosis. This is the subject of a study currently taking place at Geisinger that involves board certified pediatric endocrinologists.

Dixon was 11 years old when she pre-diagnosed herself while reading The Babysitters Club series. It was a book about the character Stacey and her diagnosis of diabetes that made Dixon think her own situation was similar.

Dixon had the same symptoms as the character in the book: excessive thirst and urination and constant fatigue.

A trip to the hospital with her mother revealed her suspicions were true.

Renee Hughes, RN, BSN, CDE, Diabetes Educator, Diabetes Center of Evangelical, West Branch Medical Center revealed the Four Cardinal Symptoms of a diabetic, includimg the frequent urination, excessive thirst fatigue and also blurred vision.

A blood test confirms the diagnosis. A blood sugar level of 126 or higher is considered diabetic. An A1C test tells the patient the average level of blood sugar over three months. Diabetic, Hughes said, is an A1C of 6.5 or higher.

Kerstetter was diagnosed in 2008 with Type 2 diabetes. The 30-year-olds main complaint at the time was intense fatigue. Upon visiting her family doctor, a blood test was taken and revealed she was Type 2 diabetic, a condition that has occurred in her fathers side of the family.

She was given pills to take not insulin and continued on that pattern for six years.

Hughes said pills that help reduce blood sugar levels are the typical first step for new Type 2 diagnosis. If the pills do not seem to help over time, injections may be prescribed. A type 2 diabetic taking injections is not necessarily taking insulin. Some injections aid in controlling the blood sugar by helping your pancreas produce the insulin naturally.

Kerstetter said this is the medication route she is currently subscribed to. In 2014 after a hospital stay for some complications with her kidneys, her new family doctor began an active look at her numbers on a regular basis to find the medication that worked best for her.

Kerstetter still takes two pills at higher doses than when she was diagnosed as well as the once-per-week injection of Tanzeum after unsuccessful results with other injections.

Dixon, meanwhile, has learned her lesson on how important it is to take her insulin regularly.

As a teenager, she said, she was not overly thrilled to be seen carrying a syringe and vile.

She said by her early 20s, after she got married, she was more compliant to take her medication because the pen form of insulin was available.

Very rarely do we have patients choose to use insulin shots, Kennedy said, It now all about the insulin pens.

Another option is an insulin pump, which Dixon said she has not used.

A catheter is placed under the skin and the pump, a small device, can be carried under a waistband and is programmed to give the correct amount of insulin required. The insulin can be adjusted as needed by pressing buttons.

However, it was the implementation of the Dexcom, Dixon said, that has changed her life. The Dexcom CGM or Continuous Glucose Monitor includes a sensor that is attached discretely to the body and then displays the glucose levels to a monitor that can be checked over 200 times a day. It can also be used in collaboration with the pump.

There is also a share option for patients to have their levels displayed on a spouses cell phone or for parents of children who need insulin.

Since Type 2 is the only preventable form of diabetes, Dohl said the key is to keep your weight under control and think about your lifestyle. She also said most patients do not consider diabetes. They often visit the doctor because they may have fainted or have blurred vision and go home with a diabetic diagnosis.

As many as 8.1 million Americans have diabetes and dont know it, Hughes said.

When symptoms arise, see your doctor and get bloodwork, they said.

Link:
Diabetes in the Valley: Area families hit hard by condition - Sunbury Daily Item

The majority of cells within our bodies are not humannor is the majority of our DNA. We are hosts to 1014 bacterial cells (50 percent to 90 percent of all cells) that make up as much as 95 percent of our total DNA.1 Most of these organisms live within the gastrointestinal (GI) tract but also within the genitourinary tract, on our skin, and on the ocular surfaceforming what is collectively known as the microbiome.

Given this abundance of nonhuman species living on and within our bodies, it is not surprising that there is a link between specific bacteria to systemic and ocular diseaseincluding diabetes and diabetes-related eye disease.

What studies tell us

A reduction in gut bacterial diversity precedes the onset of clinical diabetes.2 Reduction of intestinal species that produce short-chain fatty acids (SCFAs), especially butyrate but also propionate and acetate, appears to be particularly important. These SCFAs improve insulin sensitivity by stimulating peroxisome-proliferator agonist gamma receptors3 (PPARG), analogous to the PPARG diabetes medication, pioglitazone (Actos, Takeda).

Butyrate enhances production of the intestinal hormone, glucagon-like peptide-14 (GLP-1), which increases insulin production, decreases glucagon secretion, and inhibits appetite. It is analogous to GLP-1 analog drugs like exenatide (Byetta, Amylin) and liraglutide (Victoza, Novo Nordisk).

Butyrate also enhances intestinal barrier function, preventing translocation of bacteria and lipopolysaccharides derived from the cell walls of Gram-negative organisms (endotoxemia) that leads to so-called leaky gut syndrome. Leaky gut syndrome has been linked to autoimmunity in type 1 diabetes and inflammatory cytokine production in type 2 diabetes (T2DM).5,6

Introduction of butyrate-producing bacteria via probiotic supplementation has been shown to improve insulin sensitivity and reduce inflammation in humans with type 2 diabetes.7

Perhaps more convincingly, transplanting fecal material from healthy adults with markedly higher numbers of butyrate-producing bacteria to obese patients with T2DM and lower numbers of such bacteria resulted in nearly 80 percent better insulin sensitivity in one small study.8

Recent meta-analysis of 11 studies with more than 600 subjects shows that multi-species probiotic supplementation modestly but significantly improves insulin resistance, excess insulin production, fasting blood sugars, and mean blood glucose (HbA1c) in humans with T2DM.9

Here is the original post:
How diabetes is linked to gut bacteria - ModernMedicine

COLUMBUS, Ga. - Looking around Marquis House's bedroom in his family's Columbus, Georgia, home, it almost feels like he's still here, like he's going to walk in the door any second.

"This is all his dirty laundry; I haven't had the heart to wash it," Chereia House, his mother, says. "This is his (insulin) pen right here. His glasses he wore to school."

House spends a lot of time in here, remembering Marquis.

"I think about him," she says. "I think about his personality."

Marquis was 19, a diehard New England Patriots' fan in Falcons' country.

He was a University of West Georgia sophomore, and a video-gamer, who still got a kick out of dressing up for the family's pajama costume Christmas photo.

Marquis was also a type 1 diabetic, drilled in staying on top of his blood sugar.

"He was diagnosed when he was 4 years old," his mother remembers. "He was doing his own injections at 4, he was counting his carbs at 5."

So, losing Marquis to a complication of diabetes?

It just doesn't seem possible.

"Because he was so on top of it," Chereia House says. "He knew what to do, he always knew what to do."

And Type 1 diabetes requires a constant balancing act, says Children's Healthcare of Atlanta endocrinologist Dr. Jessica Hutchins.

"Most kids with Type 1 diabetes are taking 4 to 6 injections of insulin a day, depending on how often they're eating and how well their blood sugars are doing," Dr. Hutchins explains.

On February 11, 2017, a Saturday night, Marquis House, alone in his dorm room, called his mom.

"And he said, 'Oh, I've been throwing up.' And I said, 'What is your blood sugar?'"

Chereia House says Marquis reassured her he'd checked his blood sugar and it was within the normal range.

But he was sick to his stomach, so his mother wondered if he should go to the ER.

"He was, like, 'No, mom, I'm fine. It's just a little bug, if I'm still throwing up in the morning, I will go to the hospital,'" House says.

Marquis didn't know it, but he'd developed a serious complication, known as diabetic ketoacidosis, or DKA, often triggered by an infection or missed insulin treatments.

His insulin insulin levels had dropped dangerously low.

His body, searching for fuel for energy, had begun breaking down fat, releasing acids known as ketones into his blood, which were spilling over into his urine.

In the early stages, Dr. Hutchins says, symptoms of DKA include weight loss, an increase in thirst, and frequent urination.

Kids may feel very tired and fatigued.

But as the condition worsens, she says, patients in DKA often experience vomiting, dehydration and mental confusion.

That may explain why Marquis House simply thought he just had a stomach bug.

"Usually the symptoms have been going on for weeks, very subtly and nobody has really noticed," Dr. Hutchins says. "But as far as the actual DKA, that can, within 24 hours can go from vomiting a little bit into a severe life-threatening condition."

When she hung up with Marquis, his mother asked him to call her in the morning.

"That Sunday morning, I got up and I was, like, 'Oh, he didn't call me,' says Chereia House. "So I texted him."

Marquis never responded.

Hours later, he was dead in his dorm room.

Only now, two months after his death, is his family putting together what happened in Marquis' final hours.

"He got up at some point, and was getting ready to administer his insulin," says Chereia Houe. "Or (he was trying to) check his blood. He had everything out. And then passed out."

Today, Chereia House says, it's still hard to believe the heart of their family is gone.

"But when I miss him, I come in and I just lay across his bed," his mother says. "To kind of like get his, to get his scent."

Chereia House, still consumed by questions, says she's telling their story because she wants other parents to know about DKA and other complications of diabetes.

Follow your gut, if you feel something is wrong, she says.

She wishes more than anything she's followed hers with Marquis that February night.

"I feel if I would have pushed him, and made him go to the hospital," Chereia says. "Maybe we would not be here doing this story. Every day I live with that regret, for not pushing it.`"

NEXT ARTICLE:Brain scans may help depression patients find the right treatment

Originally posted here:
19-year old Georgia college student dies of diabetes complication - FOX 5 Atlanta

Recently, Apple (NASDAQ:AAPL) has been making headlines with a couple exciting new growth initiatives. Last week the company was granted a permit to test self-driving cars in California, and news surfaced that Apple is working on a glucose sensor to help diabetes patients.

While Apple has been focusing on these distant moonshots with little to no near-term revenue impact, their core business is quickly becoming vulnerable.

Amazon's (NASDAQ:AMZN) Alexa platform is ushering a new era of interacting with computers through voice, not touch. This is something Apple tried to do with Siri, but is miserably failing.

Instead of investing in these long-term projects, Apple needs to double down and innovate around protecting its moat around its iOS ecosystem. Building healthcare services and media content (like Planet of the Apps) would be a great start, instead of wasting time trying to compete with Tesla (NASDAQ:TSLA) in self-driving cars.

All of this and more is covered in HyperChange's weekly Sunday Schemin' podcast.

Disclosure: I am/we are long TSLA.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Visit link:
Cars? Diabetes? Is Apple A Dinosaur? - Seeking Alpha